Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of Molecular Neuroscience : MN
|
May 14, 2008
Biological and structural analysis of truncated analogs of PACAP27
Steve Bourgault, David Vaudry, Laure Guilhaudis, et al.
Journal of Neuroinflammation
|
March 22, 2019
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
Laurine Becquet, Catalina Abad, Mathilde Leclercq, et al.
Neuropharmacology
|
May 27, 2015
Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model
Asma Lamine, Myriam Létourneau, Ngoc Duc Doan, et al.
Annals of the New York Academy of Sciences
|
August 5, 2006
Expression and GTP sensitivity of peptide histidine isoleucine high-affinity-binding sites in rat
Colin Debaigt, Annie-Claire Meunier, Stephanie Goursaud, et al.
The Journal of Biological Chemistry
|
September 26, 2015
Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex
Yara Rhayem, Catherine Le Stunff, Waed Abdel Khalek, et al.
The New England Journal of Medicine
|
June 10, 2011
Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance
Agnès Linglart, Christine Menguy, Alain Couvineau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2014
The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis
David Alexandre, Coralie Hautot, Marwa Mehio, et al.
Oncotarget
|
February 23, 2018
<i>In vitro</i>, <i>in vivo</i> and <i>ex vivo</i> demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
Stéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Obesity (Silver Spring, Md.)
|
September 24, 2024
Orexins mitigate obesity-associated dysfunctions in mice
Anne Blais, Isabelle Denis, Mireille Andriamihaja, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 1, 2012
Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction
Emilie Ceraudo, Régine Hierso, Yossan-Var Tan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of Molecular Neuroscience : MN
|
May 14, 2008
Biological and structural analysis of truncated analogs of PACAP27
Steve Bourgault, David Vaudry, Laure Guilhaudis, et al.
Journal of Neuroinflammation
|
March 22, 2019
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
Laurine Becquet, Catalina Abad, Mathilde Leclercq, et al.
Neuropharmacology
|
May 27, 2015
Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model
Asma Lamine, Myriam Létourneau, Ngoc Duc Doan, et al.
Annals of the New York Academy of Sciences
|
August 5, 2006
Expression and GTP sensitivity of peptide histidine isoleucine high-affinity-binding sites in rat
Colin Debaigt, Annie-Claire Meunier, Stephanie Goursaud, et al.
The Journal of Biological Chemistry
|
September 26, 2015
Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex
Yara Rhayem, Catherine Le Stunff, Waed Abdel Khalek, et al.
The New England Journal of Medicine
|
June 10, 2011
Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance
Agnès Linglart, Christine Menguy, Alain Couvineau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2014
The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis
David Alexandre, Coralie Hautot, Marwa Mehio, et al.
Oncotarget
|
February 23, 2018
<i>In vitro</i>, <i>in vivo</i> and <i>ex vivo</i> demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
Stéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Obesity (Silver Spring, Md.)
|
September 24, 2024
Orexins mitigate obesity-associated dysfunctions in mice
Anne Blais, Isabelle Denis, Mireille Andriamihaja, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 1, 2012
Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction
Emilie Ceraudo, Régine Hierso, Yossan-Var Tan, et al.
Page
of 6